Analyze Diet
Equine veterinary journal1983; 15(3); 238-243; doi: 10.1111/j.2042-3306.1983.tb01778.x

Studies on isoxsuprine hydrochloride for the treatment of navicular disease.

Abstract: A peripheral vasodilating agent, isoxsuprine hydrochloride, administered as an oral paste, was evaluated to determine its efficacy for the treatment of navicular disease. In a clinical trial, 13 horses with navicular disease were treated at a dose rate of 0.6 mg/kg body weight (bwt) twice daily for periods of six to 14 weeks. Twelve of the horses became completely sound while being treated, although two required a 50 per cent increase in dose. Nine of the horses have remained sound two to 10 months after ceasing therapy. In a controlled randomised double blind clinical trial, 16 horses with navicular disease were assigned to treatment with either a placebo paste or isoxsuprine paste for three weeks and then re-examined. All the horses treated with isoxsuprine showed improvement in gait, with seven of eight horses becoming sound, whereas only two horses treated with a placebo paste showed slight improvement. This difference in response was highly significant (P less than 0.001). To evaluate any physiological and biochemical effects of isoxsuprine, it was administered to five Standardbred geldings at dose rates of 0.6 mg/kg bwt and 1.2 mg/kg bwt. Complete blood counts, routine plasma biochemical parameters, cardinal signs and blood pressure measurements were performed up to 24 h after a single dose. No significant change in any of these parameters was found. To assess the peripheral vasodilatory action of isoxsuprine, infra-red thermography of the lower limb was performed before and up to 8 h after administration to horses. This revealed a significant increase in distal limb temperature which occurred from 90 to 480 mins after isoxsuprine administration. The maximum mean increase in distal limb temperature was 3.1 degrees C and this occurred 4 h after administration of the drug.
Publication Date: 1983-07-01 PubMed ID: 6349984DOI: 10.1111/j.2042-3306.1983.tb01778.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study focuses on the evaluation of isoxsuprine hydrochloride’s efficacy in treating navicular disease in horses. The researchers conducted clinical trials, monitored changes in blood counts, plasma biochemical parameters, and blood pressure, and assessed the peripheral vasodilatory action of the drug.

Conducting of Clinical Trials

  • In the initial trial, 13 horses suffering from navicular disease were treated with the drug administered orally at a dose rate of 0.6 mg/kg body weight twice a day for periods extending from six to 14 weeks.
  • Throughout the treatment, 12 horses fully recovered, despite two needing a 50% dose increase. Moreover, nine horses continued to see improvement two to 10 months after stopping the therapy.

Controlled Randomised Double Blind Clinical Trial

  • The researchers also embarked on a controlled randomized double-blind clinical trial, where 16 horses suffering from navicular disease received treatment. They either received a placebo paste or the isoxsuprine paste for three weeks and were then re-examined.
  • All the horses treated with isoxsuprine showed an improvement in gait, and seven out of eight horses became sound. Only two horses treated with a placebo paste showed slight improvement, and this difference was statistically significant (P less than 0.001).

Evaluating Physiological and Biochemical Effects

  • To understand the physiological and biochemical impacts of isoxsuprine, the drug was administered to five Standardbred geldings at dose rates of 0.6 mg/kg bwt and 1.2 mg/kg bwt.
  • Complete blood counts, routine plasma biochemical parameters, cardinal signs, and blood pressure measurements were performed up to 24 hours after a single dose, and no significant change was observed in any of these parameters.

Assessment of Vasodilatory Action

  • The researchers assessed the peripheral vasodilatory action of isoxsuprine via infrared thermography of the lower limb performed before and up to 8 hours after administration to horses.
  • They observed a significant increase in the distal limb temperature that occurred 90 to 480 mins after administering isoxsuprine. The maximum mean increase in distal limb temperature was 3.1 degrees Celsius and happened four hours after the drug’s administration.

Cite This Article

APA
Rose RJ, Allen JR, Hodgson DR, Kohnke JR. (1983). Studies on isoxsuprine hydrochloride for the treatment of navicular disease. Equine Vet J, 15(3), 238-243. https://doi.org/10.1111/j.2042-3306.1983.tb01778.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 15
Issue: 3
Pages: 238-243

Researcher Affiliations

Rose, R J
    Allen, J R
      Hodgson, D R
        Kohnke, J R

          MeSH Terms

          • Administration, Oral
          • Animals
          • Body Temperature / drug effects
          • Clinical Trials as Topic
          • Double-Blind Method
          • Female
          • Foot / blood supply
          • Gait
          • Hemodynamics / drug effects
          • Horse Diseases / drug therapy
          • Horses
          • Humans
          • Ischemia / drug therapy
          • Ischemia / veterinary
          • Isoxsuprine / administration & dosage
          • Isoxsuprine / pharmacology
          • Isoxsuprine / therapeutic use
          • Lameness, Animal / drug therapy
          • Male
          • Ointments
          • Vasodilator Agents / administration & dosage
          • Vasodilator Agents / pharmacology
          • Vasodilator Agents / therapeutic use

          Citations

          This article has been cited 0 times.